Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetic acid versus mupirocin for peritoneal dialysis exit-site infection prevention
ACTRN12617001286336Phase 2Completed
- Sponsor
- Mrs Lesley Williams
- Start
- Feb 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetic acid and mupirocin (2 arms), sponsored by Mrs Lesley Williams. Primary endpoints: Time to first exit-site infection, Rate of exit-site infection and 1 more. Started Feb 2018; status: completed.
02
Drugs
acetic acidmupirocin
Beyond the preview
Go deeper on ACTRN12617001286336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001286336.